Related Experiment Video
Updated: Dec 23, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Field Implementation of Remote Ischemic Conditioning in ST-Segment-Elevation Myocardial Infarction: The FIRST Study
Sheldon Cheskes1, Maria Koh2, Linda Turner3
1Division of Emergency Medicine, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Centre for Prehospital Medicine, Toronto, Ontario, Canada; Li Ka Shing Knowledge Institute, St Michaels Hospital, Toronto, Ontario, Canada.
Remote ischemic conditioning (RIC) before percutaneous coronary intervention (PCI) for ST-segment-elevation myocardial infarction (STEMI) did not reduce major adverse cardiovascular events (MACE). However, RIC showed potential benefit for high-risk patients with cardiogenic shock or cardiac arrest.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Remote ischemic conditioning (RIC) is a noninvasive method to protect the heart from ischemia-reperfusion injury.
- RIC involves brief cycles of blood pressure cuff inflation and deflation.
- This study evaluated RIC's impact on major adverse cardiovascular events (MACE) in ST-segment-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI).
Purpose of the Study:
- To compare MACE rates in STEMI patients receiving RIC before PCI versus standard care.
- To assess the efficacy of RIC as a pre-PCI therapy for STEMI.
Main Methods:
- A pre- and postimplementation study design was used.
- STEMI patients received either standard care or RIC (4 cycles) before PCI.
- Propensity score weighting was employed to adjust for baseline differences and estimate causal effects on MACE at 30, 90, and 180 days.
Main Results:
- A total of 1667 patients were analyzed (866 preimplementation, 801 postimplementation).
- No significant difference in 90-day MACE was observed between the RIC and standard care groups (11.8% vs 13.4%; OR 0.86).
- RIC significantly reduced 90-day MACE in patients presenting with cardiogenic shock or cardiac arrest (27.8% vs 42.7%; OR 0.52).
Conclusions:
- RIC before PCI for STEMI did not significantly reduce 90-day MACE overall.
- RIC demonstrated a potential benefit in reducing MACE for high-risk STEMI patients with cardiogenic shock or cardiac arrest.
- Further research is warranted to explore RIC's long-term effects and its specific role in managing high-risk STEMI populations.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care

